The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded ...

The Centers for Medicare and Medicaid (CMS) announced Friday it will not be finalizing a rule proposed by the Biden ...

President Donald Trump’s administration has decided not to cover expensive, high-demand obesity treatments under the ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Trump officials reject Medicare coverage ...

A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases ...

Get Instant Summarized Text (Gist) Expanding access to anti-obesity medications could yield a 13% annual return on investment for society by increasing life expectancy and reducing obesity-related ...

Expanding access to anti-obesity medications for all adults without diabetes who qualify would generate $10 trillion in social value by enabling people to live longer and healthier lives ...

A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases in life expectancy and disease-free years while generating a ...

A large majority of older Americans feel that health insurance – including Medicare – should cover anti-obesity medications, according to a new University of Michigan study. And more than half ...

are denied coverage for anti-obesity medications, even though these treatments have been shown to reduce weight, improve overall health, prevent or manage obesity-related conditions, and for some ...